Zhucheng Haotian Pharm Co. Ltd., commonly referred to as Haotian Pharm, is a prominent player in the pharmaceutical industry, headquartered in Zhucheng, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs), catering to both domestic and international markets. With a strong focus on research and development, Haotian Pharm offers a diverse range of products, including anti-infectives and cardiovascular medications, distinguished by their adherence to stringent quality standards. The company has achieved notable recognition for its commitment to innovation and sustainability, positioning itself as a trusted partner in the global pharmaceutical supply chain. Through its strategic operational regions across Asia and beyond, Zhucheng Haotian Pharm Co. Ltd. continues to enhance its market presence and contribute to advancements in healthcare.
How does Zhucheng Haotian Pharm Co. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Zhucheng Haotian Pharm Co. Ltd.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zhucheng Haotian Pharm Co. Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Zhucheng Haotian Pharm may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Zhucheng Haotian Pharm to consider developing and disclosing their climate strategies to align with global efforts in reducing greenhouse gas emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zhucheng Haotian Pharm Co. Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
